Alloy Therapeutics, Inc.
Waltham, US · Founded 2020 · Delaware corporation · 5 known investors
Biotech
Founders & leadership
AS
Anthony SunDirector
AH
Alaa HalawaDirector
UN
Ulrik NielsenDirector
JC
Jason CammDirector
JC
Jason ColomaDirector
CK
Christian KanadyDirector
AK
Alex KolicichDirector
EB
Errik B. AndersonExecutive Officer, Director
PB
Piotr BobrowiczExecutive Officer, Director
LS
Logan SnyderDirector
JR
Jay RosanelliExecutive Officer
FH
Fabian HansenDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$30MraisedApr 2026 · 11 investors · BiotechnologyRule 506(b)
▶$30MraisedApr 2026 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony SunDirector
- Alaa HalawaDirector
- Ulrik NielsenDirector
- Jason CammDirector
- Jason ColomaDirector
- Christian KanadyDirector
- Alex KolicichDirector
- Errik B. AndersonExecutive Officer, Director
- Piotr BobrowiczExecutive Officer, Director
- Logan SnyderDirector
- Offering amount
- $40M
- Amount sold
- $30M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.7MraisedOct 2022 · 13 investors · BiotechnologyRule 506(b)
▶$41.7MraisedOct 2022 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony SunDirector
- Alaa HalawaDirector
- Ulrik NielsenDirector
- Piotr BobrowiczExecutive Officer, Director
- Jason CammDirector
- Errik B. AndersonExecutive Officer, Director
- Logan SnyderExecutive Officer, Director
- Fabian HansenDirector
- Alex KolicichDirector
- Jason ColomaDirector
- Offering amount
- $41.7M
- Amount sold
- $41.7M
- Proceeds to insiders
- $1M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$75MraisedApr 2021 · 17 investors · BiotechnologyRule 506(b)
▶$75MraisedApr 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Piotr BobrowiczExecutive Officer, Director
- Ulrik NielsenDirector
- Jay RosanelliExecutive Officer
- Jason ColomaDirector
- Errik B. AndersonExecutive Officer, Director
- Fabian HansenDirector
- Jason CammDirector
- Alex KolicichDirector
- Logan SnyderExecutive Officer, Director
- Offering amount
- $75M
- Amount sold
- $75M
- Proceeds to insiders
- $1M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.